AMITA Health Accountable Care Organization LLC | Ascension

ACO name and location

AMITA Health Accountable Care Organization, LLC
200 S. Wacker Dr.
Floor 11
Chicago, IL 60606

ACO primary contact

Primary contact name: Dave Hurter
Primary contact phone Number: 847-759-4490
Primary contact email address: AHACO@ascension.org

Organizational information

ACO participants:

ACO participants ACO participant in joint venture (Enter Y or N)
Adventist Health Partners, Inc. N
Alexian Brothers Medical Care Group, NFP N
ALLIANCE INTERNAL MEDICINE, S.C. N
AMISHI SAWLANI N
BARBATO & ZBIEGIEN MD SC N
Bonaventure Medical Foundation, Llc N
 Center for Adult Healthcare SC
Chinmay Patel N
CLINICAL ASSOCIATES IN MEDICINE, LLC N
COLETTE GORDON N
DATTA SAMBARE M D S C N
Dupage Internal Medicine, L.L.C N
EILEEN HEFFERNAN N
FAMILY CARE ASSOCIATES LTD N
FAMILY HEALTH CENTER OF PLAINFIELD, LTD. N
Family Medical Center of LaGrange, Ltd. N
FIRST CARE FAMILY CLINIC, S.C. N
HEARTLAND PRIMARY CARE S C N
HORIZON MEDICAL CENTER LTD N
Howard S. Mangurten MD, SC N
INTERNAL MEDICINE & FAMILY PRACTICE. S.C. N
INTERNAL MEDICINE SPECIALISTS OF KANKAKEE SC N
JUDY JOSEPH N
 Lifetime Family Healthcare LTD
LISA KIM MEDICAL ASSOCIATES SC N
 Maple Health Primary Care PLLC N
MCINTYRE FAMILY MEDICINE LLC N
MPS Kohli MD,SC N
NANI INTERNAL MED LLC N
NARSEEN HAMIDANI INTERNAL MEDICINE PLLC N
OLGA SAAVEDRA N
PRESENCE HEALTHCARE SERVICES N
PRIMARY CARE PROVIDERS OF CHICAGO SC N
Ramesh Melvani S C INC N
ROGERS MEDICAL, LTD N
ROGERS PARK FAMILY MEDICINE SC N
SANJAY PETHKAR, M.D., S. C. N
SIMON WU MD LTD N
SPS FAMILY CARE, S.C. N
SRINIVAS C KOTA MD SC N
ST MARY INTERNAL MEDICINE ASSOCIATES S C N

ACO governing body:

Member first name Member last name Member title/position Member's voting power (expressed as a percentage) Membership type ACO participant legal business name, if applicable
 Mehul  Shah MD/Board Chair and Director
7.7   ACO Participant Representative  Primary Care Providers of Chicago SC
Ken Nelson MD/Vice Chair and Director 7.7 ACO Participant Representative
Adventist Health Partners, Inc
Michael Dupont MD/Board Director 7.7  ACO Participant Representative Family Medical Center of LaGrange, Ltd.
Mark Collins MD/Board Director 7.7 ACO Participant Representative Bonaventure Medical Foundation, LLC
Kevin Kalafut MD/Board Director 7.7 ACO Participant Representative Adventist Health Partners, Inc.
John Wilkerson MD/Board Director 7.7 ACO Participant Representative Bonaventure Medical Foundation, LLC
Jonathan Maks MD/Board Director 7.7 ACO Participant Representative Presence Healthcare Services
Christina Adams Medicare Beneficiary/Board Director 7.7 Medicare Beneficiary Representative  N/A
Daniel Sauri MD/Board Director 7.7 Other  
Reinhold Llerena MD/Board Director 7.7 ACO Participant Representative Bonaventure Medical Foundation, LLC
Andrew Palumbo Board Director 7.7 ACO Participant Representative Bonaventure Medical Foundation, LLC
David Hurter AMITA Health ACO CEO/Ex Officio 0 Other  
Justin Johnson Board Treasurer 0 Other  
Tobia Barbato MD/Board Director 7.7 ACO Participant Representative Barbato & Zbiegien MD SC
David Bordo MD/Board Director 7.7 ACO Participant Representative Presence Healthcare Services

Due to rounding, ‘Member’s Voting Power’ may not equal 100 percent

  • Key ACO clinical and administrative leadership:
    • ACO Executive: David Hurter
    • Medical Director: Reinhold Llerena, MD
    • Compliance Officer: Kathryn Yurkovich
    • Quality Assurance/Improvement Officer: Michele Winiarz
  • Associated committees and committee leadership:
    Committee name Committee leader name and position
    Medical Management Committee Dr. Daniel Sauri, Chair
    Network Participation and Provider Selection Committee Dr. John Wilkerson, Chair
    Finance and Contracting Committee Dr. Maninder Kohli, Chair
  • Types of ACO participants or combinations of participants that formed the ACO:
    • ACO professionals in a group practice arrangement
    • Partnerships or joint venture arrangements between hospitals and ACO professionals
    • Network of individual practices of ACO professionals

Shared savings and losses

Amount of shared savings and losses

Third agreement period

  • Performance Year 2022, $11,532,556
  • Performance Year 2021, $9,393,607
  • Performance Year 2020, $11,955,044
  • Performance Year 2019, $4,527,805

Second agreement period

  • Performance Year 2019, $4,527,805
  • Performance Year 2018, $7,273,754
  • Performance Year 2017, $27,325,327
  • Performance Year 2016, $20,489,157

First agreement period

  • Performance Year 2015, $0
  • Performance Year 2014, $0
  • Performance Year 2013, $0

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Shared Savings Distribution

Third agreement period

Performance 2022

  • Proportion invested in infrastructure: 10%
  • Proportion invested in redesigned care processes/resources: 15%
  • Proportion of distribution to ACO participants: 75%

Performance 2021

  • Proportion invested in infrastructure: 10%
  • Proportion invested in redesigned care processes/resources: 15%
  • Proportion of distribution to ACO participants: 75%

Performance 2020

  • Proportion invested in infrastructure: 10%
  • Proportion invested in redesigned care processes/resources: 15%
  • Proportion of distribution to ACO participants: 75%

Performance Year 2019

  • Proportion invested in infrastructure: 10%
  • Proportion invested in redesigned care processes/resources: 15%
  • Proportion of distribution to ACO participants: 75%

Second agreement period

Performance Year 2019

  • Proportion invested in infrastructure: 10%
  • Proportion invested in redesigned care processes/resources: 15%
  • Proportion of distribution to ACO participants: 75%

Performance Year 2018

  • Proportion invested in infrastructure: 10%
  • Proportion invested in redesigned care processes/resources: 15%
  • Proportion of distribution to ACO participants: 75%

Performance Year 2017

  • Proportion invested in infrastructure: 10%
  • Proportion invested in redesigned care processes/resources: 15%
  • Proportion of distribution to ACO participants: 75%

Performance Year 2016

  • Proportion invested in infrastructure: 10%
  • Proportion invested in redesigned care processes/resources: 10%
  • Proportion of distribution to ACO participants: 80%

First agreement period

Performance Year 2015

  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A

Performance Year 2014

  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A

Performance Year 2013

  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Quality performance results

2022 quality performance results:

Quality performance results are based on CMS Web Interface

Measure # Measure name  Collection Type

Reported Performance Rate

Current Year Mean Performance Rate (SSP ACOs)
Measure #: 001  Diabetes: Hemoglobin A1c (HbA1c)  CMS Web Interface  7.84  10.71  
Measure #: 134  Preventative Care and Screening: Screening for Depression and Follow-up Plan  CMS Web Interface  84.15 76.97
Measure #: 236  Controlling High Blood Pressure CMS Web Interface  76.44  76.16 
Measure #: 318  Falls: Screening for Future Fall Risk CMS Web Interface  96.06 87.83
Measure #: 110  Preventative Care and Screening: Influenza Immunization CMS Web Interface 88.81 77.34
Measure #: 226 Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention CMS Web Interface   83.33 79.27
Measure #: 113  Colorectal Cancer Screening CMS Web Interface  79.12  75.32
Measure #: 112  Breast Cancer Screening CMS Web Interface 80.08 78.07 
Measure #: 438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease CMS Web Interface 87.56 86.37
Measure #: 370 Depression Remission at Twelve Months  CMS Web Interface 
4.26  16.03 
Measure #: 479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups  Administrative Claims .1546 .1510
Measure #: 484  Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions  Administrative Claims 34.69  30.97
CAHPS-1 Getting Timely Care, Appointments, and Information CAHPS for MIPS Survey 85.91 83.96
CAHPS-2 How Well Providers Communicate CAHPS for MIPS Survey 94.52 93.56
CAHPS-3 Patient’s Rating of Provider CAHPS for MIPS Survey
92.51  96.06
CAHPS-4 Access to Specialists CAHPS for MIPS Survey 79.38  77.00
CAHPS-5 Health Promotion and Education CAHPS for MIPS Survey
65.28 62.68
CAHPS-6 Shared Decision Making CAHPS for MIPS Survey
62.85 60.97
CAHPS-7 Health Status and Functional Status CAHPS for MIPS Survey
72.91  73.06
CAHPS-8 Care Coordination CAHPS for MIPS Survey
86.17 85.46
CAHPS-9 Courteous and Helpful Office Staff CAHPS for MIPS Survey
90.91 91.91
CAHPS-11 Stewardship of Patient Resources CAHPS for MIPS Survey
26.80 25.62

For Previous Years' Financial and Quality Performance Results, please visit data.cms.gov

Payment rule waivers

  • Skilled Nursing Facility (SNF) 3-day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.